Ledger.Open graph →
SEC Form D · Amendment · filed June 2, 2010

Nora Therapeutics, Inc

Offering
$25.1M
Sold
$2.9M
Exemption
—
Industry
Biotechnology
Location
OWINGS MILLS, MD
Type
—

People & firms on this filing (12)

Donald J. Hayden, Jr · Owing Mills, MDDirectorChristopher B. Mcclain · Owing Mills, MDExecDarryl L. Carter · Owing Mills, MDExecChen E. Yu · Palo Alto, CADirectorBryant E. Fong · San Francisco, CADirectorDavid E. Schnell · Palo Alto, CADirectorBruce Gittlin · New York, NYExecWilliam H. Reaves · Jersey City, NJExecWilliam A. Ferer · Jersey City, NJDirectorRonald J. Sorenson · Jersey City, NJDirectorTimothy O. Porter · Jersey City, NJDirectorJohn P. Bartlett · Jersey City, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗